Logo image of PL

PLANET LABS PBC (PL) Stock Fundamental Analysis

NYSE:PL - New York Stock Exchange, Inc. - US72703X1063 - Common Stock - Currency: USD

6.47  -0.37 (-5.41%)

Fundamental Rating

4

Overall PL gets a fundamental rating of 4 out of 10. We evaluated PL against 81 industry peers in the Professional Services industry. No worries on liquidiy or solvency for PL as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, PL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PL had negative earnings in the past year.
PL had a positive operating cash flow in the past year.
In the past 5 years PL always reported negative net income.
In the past 5 years PL always reported negative operating cash flow.
PL Yearly Net Income VS EBIT VS OCF VS FCFPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

The Return On Assets of PL (-16.18%) is worse than 81.48% of its industry peers.
PL's Return On Equity of -23.95% is on the low side compared to the rest of the industry. PL is outperformed by 76.54% of its industry peers.
Industry RankSector Rank
ROA -16.18%
ROE -23.95%
ROIC N/A
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
PL Yearly ROA, ROE, ROICPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 58.35%, PL is in the better half of the industry, outperforming 71.60% of the companies in the same industry.
PL's Gross Margin has improved in the last couple of years.
PL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
PL Yearly Profit, Operating, Gross MarginsPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PL has been increased compared to 1 year ago.
Compared to 5 years ago, PL has more shares outstanding
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PL Yearly Shares OutstandingPL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
PL Yearly Total Debt VS Total AssetsPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

PL has an Altman-Z score of 3.47. This indicates that PL is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PL (3.47) is better than 62.96% of its industry peers.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.47
ROIC/WACCN/A
WACC8.97%
PL Yearly LT Debt VS Equity VS FCFPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

PL has a Current Ratio of 2.10. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
PL's Current ratio of 2.10 is fine compared to the rest of the industry. PL outperforms 79.01% of its industry peers.
A Quick Ratio of 2.10 indicates that PL has no problem at all paying its short term obligations.
PL has a Quick ratio of 2.10. This is in the better half of the industry: PL outperforms 79.01% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1
PL Yearly Current Assets VS Current LiabilitesPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.43% over the past year.
PL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.52%.
PL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.62% yearly.
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)9.52%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%9.64%

3.2 Future

Based on estimates for the next years, PL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.05% on average per year.
Based on estimates for the next years, PL will show a quite strong growth in Revenue. The Revenue will grow by 18.40% on average per year.
EPS Next Y34.49%
EPS Next 2Y25.1%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue Next Year11.61%
Revenue Next 2Y16.01%
Revenue Next 3Y18.4%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PL Yearly Revenue VS EstimatesPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
PL Yearly EPS VS EstimatesPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PL. In the last year negative earnings were reported.
Also next year PL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PL Price Earnings VS Forward Price EarningsPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PL Per share dataPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PL's earnings are expected to grow with 25.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.1%
EPS Next 3Y25.05%

More info and screens

0

5. Dividend

5.1 Amount

PL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLANET LABS PBC

NYSE:PL (8/19/2025, 3:10:04 PM)

6.47

-0.37 (-5.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)09-08 2025-09-08/amc
Inst Owners54.69%
Inst Owner Change14.29%
Ins Owners1.82%
Ins Owner Change3.88%
Market Cap1.96B
Analysts82.11
Price Target7 (8.19%)
Short Float %5.64%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.96%
Min EPS beat(2)-217.93%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)-14.48%
Min EPS beat(4)-217.93%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)4.53%
EPS beat(12)11
Avg EPS beat(12)7.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.07%
Min Revenue beat(2)-3.41%
Max Revenue beat(2)3.27%
Revenue beat(4)1
Avg Revenue beat(4)-2.49%
Min Revenue beat(4)-5.77%
Max Revenue beat(4)3.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.54%
Revenue beat(12)3
Avg Revenue beat(12)-1.04%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.33%
PT rev (3m)24.11%
EPS NQ rev (1m)2.06%
EPS NQ rev (3m)2.72%
EPS NY rev (1m)0%
EPS NY rev (3m)24.96%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.85
P/FCF N/A
P/OCF 270.08
P/B 4.41
P/tB 7.59
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)0.02
OCFY0.37%
SpS0.82
BVpS1.47
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.18%
ROE -23.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.35%
FCFM N/A
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 109.15%
Cap/Sales 19.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z 3.47
F-Score6
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)75.73%
Cap/Depr(5y)61.76%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y34.49%
EPS Next 2Y25.1%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue 1Y (TTM)9.52%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%9.64%
Revenue Next Year11.61%
Revenue Next 2Y16.01%
Revenue Next 3Y18.4%
Revenue Next 5YN/A
EBIT growth 1Y37.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.13%
EBIT Next 3Y45%
EBIT Next 5YN/A
FCF growth 1Y64.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.42%
OCF growth 3YN/A
OCF growth 5YN/A